Hunan Fangsheng Pharmaceutical Co., Ltd. Class ASSE: 603998

"HUNAN FANGSHENG PHARMACEUTICAL CO., LTD."Announcement on Resignation of Director and Deputy General Manager

Aug 27, 2026 · Issued by Hunan Fangsheng Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Resignation of Director and Deputy General Manager

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Hunan Fangsheng Pharmaceutical Co., Ltd. Class A

"HUNAN FANGSHENG PHARMACEUTICAL CO., LTD."Announcement on Progress of the Company's Acquisition of Pharmaceutical Production TechnologyAug 26
"HUNAN FANGSHENG PHARMACEUTICAL CO., LTD."Announcement on Convening the 2026 Semi-annual Performance and Cash Dividend BriefingAug 21
"HUNAN FANGSHENG PHARMACEUTICAL CO., LTD."Announcement on Proposed Selection of the Company's Products in the 12th Batch of the National Organized Centralized Volume-Based Drug ProcurementAug 4
"HUNAN FANGSHENG PHARMACEUTICAL CO., LTD."Announcement on Progress in Signing the Project Repurchase AgreementJul 29

All Hunan Fangsheng Pharmaceutical Co., Ltd. Class A news releases